Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-031781

President and CEO sold 217,515 shares at an average $15.35 ($3,338,725)

  • President and CEO acquired 250,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Polymeropoulos Mihael Hristos · President and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-17 Exercise or conversion : show line 1 in the form +97,373 $12.55 $1,222,031 1,276,343 D
2019-05-17 Sale : show line 2 in the form −77,225 $15.56 $1,201,691 1,199,118 D
2019-05-20 Exercise or conversion : show line 3 in the form +73,608 $12.55 $923,780 1,272,726 D
2019-05-20 Sale : show line 4 in the form −67,418 $15.12 $1,019,084 1,205,308 D
2019-05-21 Exercise or conversion : show line 5 in the form +79,019 $12.55 $991,688 1,284,327 D
2019-05-21 Sale : show line 6 in the form −72,872 $15.34 $1,117,951 1,211,455 D
Open-market sales · 217,515 sh · avg $15.35 · $3,338,725

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2019-05-17 Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) −97,373 152,627 D
2019-05-20 Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) −73,608 79,019 D
2019-05-21 Exercise or conversion : show line 9 in the form Employee Stock Option (Right to Buy) −79,019 0 D
Loading xslF345X03/doc4.xml…